Literature DB >> 7965737

Multiple systems for the biliary excretion of organic anions in rats: liquiritigenin conjugates as model compounds.

H Shimamura1, H Suzuki, M Hanano, A Suzuki, O Tagaya, T Horie, Y Sugiyama.   

Abstract

Liquiritigenin (LG), 2, 3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-(S)-4H-1-benzopyran-4-1, is metabolized to five kinds of conjugates (glucuronides and sulfates) that are excreted predominantly into the bile (Shimamura et al., 1993). Using LG as a model compound, we studied the multiplicity for the biliary excretion of conjugates in vivo. LG was administered i.v. as a bolus to Sprague-Dawley rats (SD rats) that received i.v. infusions of the inhibitors [glycyrrhizin (GR), dibromosulfophthalein (DBSP) and indocyanine green (ICG)] at their maximal transport rates. The infusion of GR and that of DBSP reduced significantly the biliary excretion of all the conjugates except LG 4',7-O-disulfate (M3), whereas infusion of ICG did not affect the excretion of conjugates. To minimize the effect of the other tissues on the disposition of the conjugates, the apparent biliary excretion clearance (CLbile,app) was calculated. The CLbile,app values of LG 4'-O-glucuronide (M1), LG 7-O-glucuronide (M2), LG 4'-O-glucuronide 7-O-sulfate (M4) and LG 7-O-glucuronide 4'-O-sulfate (M5) were significantly reduced by GR and DBSP infusion, whereas the CLbile, app value of M3 was not affected by these inhibitors. The CLbile, app values of all the conjugates except M2 were not reduced by ICG infusion. In Eisai hyperbilirubinemic rats, which have a hereditary defect in the canalicular transport system for several organic anions, the biliary excretion clearance of M1, M2, M4 and M5 was markedly reduced, whereas that of M3 was comparable with that in control rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965737

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Effects of organic anions and bile acid conjugates on biliary excretion of pravastatin in the rat.

Authors:  S Fukumura; H Takikawa; M Yamanaka
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

Review 2.  Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.

Authors:  M Yamazaki; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

3.  Biliary excretion of glycyrrhizin in rats: kinetic basis for multiplicity in bile canalicular transport of organic anions.

Authors:  H Shimamura; H Suzuki; O Tagaya; T Horie; Y Sugiyama
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

4.  Enhanced biliary excretion of lithocholate-3-sulfate by ursodeoxycholate-3,7-disulfate infusion in Eisai hyperbilirubinemic rat (EHBR).

Authors:  H Takikawa; N Sano; T Ogasawara; M Yamanaka
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

5.  Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.

Authors:  O Takenaka; T Horie; K Kobayashi; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.